These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11069040)

  • 21. Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients.
    Miano M; Pistorio A; Putti MC; Dufour C; Messina C; Barisone E; Ziino O; Parasole R; Luciani M; Lo Nigro L; De Rossi G; Varotto S; Bertorello N; Petruzziello F; Calvillo M; Micalizzi C
    Leuk Lymphoma; 2012 Sep; 53(9):1693-8. PubMed ID: 22303898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute lymphoblastic leukemia presenting as non-oliguric renal failure and hypertension.
    Gupta N; Gupta SK; Rathi S; Sharma SK; Mahapatra M; Seth T; Mishra P; Saxena R
    Leuk Res; 2010 Jul; 34(7):e150-1. PubMed ID: 20089303
    [No Abstract]   [Full Text] [Related]  

  • 23. Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients.
    O'Neill KL; Zhang F; Li H; Fuja DG; Murray BK
    Leukemia; 2007 Mar; 21(3):560-3. PubMed ID: 17252017
    [No Abstract]   [Full Text] [Related]  

  • 24. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy.
    Abruzzo LV; Jaffe ES; Cotelingam JD; Whang-Peng J; Del Duca V; Medeiros LJ
    Am J Surg Pathol; 1992 Mar; 16(3):236-45. PubMed ID: 1599015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of short-course high-dose methylprednisolone on peripheral blood lymphocyte subsets in children with acute leukemia during remission induction treatment.
    Tunç B; Oner AF; Hiçsönmez G
    Leuk Res; 2003 Jan; 27(1):19-21. PubMed ID: 12479848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with early reinduction chemotherapy for adults with acute myeloid leukemia.
    Ueda M; Xie H; Sandhu RK; Walter RB; Pagel JM; Estey EH
    Leuk Lymphoma; 2015 Mar; 56(3):782-4. PubMed ID: 24882254
    [No Abstract]   [Full Text] [Related]  

  • 27. Minimally differentiated acute leukemia.
    Cadwell FJ; Burns CP; Dick FR; Jones MP; Heckman KD; Weiner GJ; Goeken JA
    Leuk Res; 1993 Mar; 17(3):199-208. PubMed ID: 8450670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study employing combination regimens containing KRN8602 in drug-resistant acute myeloid leukemia and acute lymphoblastic leukemia. KRN8602 Leukemia Study Group.
    Kishimoto Y; Sampi K; Kuraishi Y; Takemoto Y; Okabe K; Tamura K; Mizoguchi H; Saito H; Masaoka T; Ogawa M
    Anticancer Drugs; 1999 Mar; 10(3):267-73. PubMed ID: 10327031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH; Kitchen S; Saravia O; Velasquez WS
    Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How high can we increase complete remission rate in adult acute myeloid leukemia?
    Ohno R
    Int J Hematol; 2000 Oct; 72(3):272-9. PubMed ID: 11185981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of acute leukemia.
    Lechner K; Geissler K; Jäger U; Greinix H; Kalhs P
    Ann Oncol; 1999; 10 Suppl 6():45-51. PubMed ID: 10676552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute myeloid leukemia originating from the same leukemia clone after the complete remission of acute lymphoid leukemia].
    Matsuda I; Nakamaki T; Amaya H; Kiyosaki M; Kawakami K; Yamada K; Yokoyama A; Hino K; Tomoyasu S
    Rinsho Ketsueki; 2003 Sep; 44(9):946-51. PubMed ID: 14577315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Various aspects of bone marrow cell proliferation in acute leukemia].
    Shmarov DA; Kuchma IuM; Kozinets GI
    Ter Arkh; 2001; 73(12):73-7. PubMed ID: 11858117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
    Rothe G; Schmitz G
    Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of myeloid or lymphoid acute leukemia by a chemiluminescence assay. Comparison with immunocytochemistry using an antimyeloperoxidase antibody.
    da Fonseca LM; Brunetti IL; Rego EM; Garcia AB; Cilento G; Falcão RP
    Acta Haematol; 1993; 90(1):19-24. PubMed ID: 8237269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived.
    Farshchi Zarabi S; Chan S; Gupta V; Khalaf D; Lutynski A; Minden MD; Rostom A; Rydlewski A; Schuh AC; Sibai H; Yee KWL; Schimmer AD
    Leuk Lymphoma; 2018 Jan; 59(1):237-240. PubMed ID: 28595467
    [No Abstract]   [Full Text] [Related]  

  • 38. Last exit clofarabine?
    Faderl S
    Leuk Lymphoma; 2009 Dec; 50(12):1907-8. PubMed ID: 20001243
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunophenotyping of leukemia.
    Campana D; Behm FG
    J Immunol Methods; 2000 Sep; 243(1-2):59-75. PubMed ID: 10986407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.